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Abstract 
Discogenic lower back pain (DLBP) is the most common type of chronic lower back pain 
(LBP), accounting for 39% of cases, compared to 30% of cases due to disc herniation, and 
even lower prevalence rates for other causes, such as zygapophysial joint pain. Only a small 
proportion (approximately 20%) of LBP cases can be attributed with reasonable certainty to 
a pathologic or anatomical entity. Thus, diagnosing the cause of LBP represents the biggest 
challenge for doctors in this field. In this review, we summarize the process of obtaining a 
clinical diagnosis of DLBP and discuss the potential for serum-based diagnosis in the near 
future. The use of serum biomarkers to diagnose DLBP is likely to increase the ease of di-
agnosis as well as produce more accurate and reproducible results.   
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Introduction 
Research shows that an estimated 80% of the 
population will suffer from lower back pain (LBP) at 
some time in their lives. Many of these people will 
probably suffer LBP on many occasions, and chronic 
LBP is the biggest factor limiting activity in young 
adults under the age of 45. Epidemiological investi-
gations in the United States revealed an estimated 
5-20% yearly prevalence of LBP. LBP interferes with 
the daily lives of patients, eventually decreasing their 
quality of life. The costs associated with this condition 
are enormous, including both direct medical costs and 
indirect costs, such as decreased productivity in the 
workplace. LBP is therefore not only a health problem 
but also a socio-economic problem. 
Pathology 
Disc degeneration in humans can begin as early 
as the third decade of life. Aging, obesity, smoking, 
vibrations from transportation, excessive axial loads, 
and other factors accelerate the degeneration of in-
tervertebral discs [1-3]. Anderson et al. [4] found that 
disc degeneration was one of the main reasons for 
chronic LBP. At present, most data show that chronic 
LBP is most closely related to the anatomical structure 
of the intervertebral disc, particularly in patients with 
no obvious herniation of the nucleus pulposus, rep-
resenting the clinical pathology of the disease process 
known as discogenic lower back pain (DLBP). DLBP is 
the most common disease of chronic LBP, accounting 
for 39% of its incidence. Lower disc herniation (LDH) 
represents less than 30% of cases, and other causes, 
such as zygapophysial joint pain, are responsible for 
an even lower proportion of LBP cases. 
DLBP is a loss of lower back function with pain. 
While the external outline of the disc may remain in-
tact, multiple processes (degeneration, end plate in-
jury, inflammation, etc.) can internally stimulate pain 
receptors inside the disc without nerve root symp-Int. J. Biol. Sci. 2009, 5 
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toms. Additionally, there is no root symptom, and no 
evidence of segmental activities of the radiology. Disc 
disorders were first documented by Crock in 1970, 
and the term DLBP was coined in 1979. Since then, 
many scholars have conducted in-depth studies on 
this condition. According to epidemiological investi-
gations, DLBP is a complex disease with genetic, 
community and mental health implications. Patient 
groups with a genetic susceptibility to DLBP are con-
sidered high-risk and experience changes in the 
chemical and biological composition of their in-
tervertebral discs, as well as metabolic changes in 
their bodies. Abnormal stresses reduce the amount of 
water in the nucleus gelatinosus, inducing degenera-
tion of the disc. The disc is then unable to bear stress 
evenly, and localized increase in stress cause struc-
tural injuries that lead to a tear or rupture in the an-
nular fibrosis and end plate. Damage to the end plate 
accelerates the pathological process of disc degenera-
tion. During this degenerative process, cells of the disc 
nucleus generate an inflammatory response, releasing 
a large number of inflammatory factors or cytokines. 
Studies have suggested that patients with DLBP have 
significantly higher levels of released interleukin-1 
(IL-1), IL-6, and IL-8 compared to patients with disc 
herniation [5]. These inflammatory factors travel into 
the fission of the end plate or the outer third of the 
annular fibrosus, stimulate pain receptors (free nerve 
endings), and cause pain (Figure 1). Therefore, DLBP 
requires two factors to induce pain: the existence of 
free nerve endings, namely pain receptors, and in-
flammation. There is a high density of nerves and 
blood vessels in the outer third of the annulus and 
end plate area, which is likely the site where pain is 
produced. As mentioned, a large number of inflam-
matory factors are produced by the cells of the nu-
cleus, which act on pain receptors to produce pain. 
Thus, the inflammatory response is the main patho-
physiologic cause of DLBP.  
 
 
Figure 1. The pathogenesis of discogenic lower back pain  
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Clinical diagnosis 
Only a small proportion (approximately 20%) of 
LBP cases can be attributed with reasonable certainty 
to a pathologic or anatomical entity. Thus, diagnosing 
the cause of LBP represents the biggest challenge for 
doctors in this field. Persistent LBP treatments are 
often unsatisfactory due to the lack of a precise diag-
nosis. At present, the following methods are used to 
identify the cause of LBP. 
Centralization phenomenon (CP) and bony vibration test 
(BVT) 
Because most of the signs and symptoms of 
DLBP are not specific and are difficult to distinguish 
from the other diseases that exhibit LBP, the pain 
centralization and the shock-induced bone pain 
methods can be used to determine a diagnosis. 
Mckenzie in 1981 first described the centralization 
phenomenon, which consists of pain in the central line 
of the spine upon lateral movement. This is also 
known as the Mckenzie assessment, suggesting that 
the LBP originates in the disc. Later, Wetzel [6] re-
searched the mechanism of the CP and showed that 
Spinal movements may return the displaced or re-
moved nucleus to its normal position along the crack 
of the disc, resulting in pain along the central line of 
the spine. Donelson et al. [7] found that the presence 
of the CP had a sensitivity of 64% and specificity of 
70% for DLBP, suggesting that the CP could be a di-
agnostic indicator of DLBP [8]. Young et al. [9] indi-
cated a specificity of 100%, an odds ratio (OR) of 2.13, 
and a confidence interval (CI) of 1.28 ~ 3.52. In a re-
cent study [10], the CP observed in discographies of 
patients with severe disabilities was 97% specific to 
DLBP, supporting the above findings. Furthermore, 
the CP may be a good predictor for chronic LBP relief 
with surgery [11] because patients with the CP had an 
increased level of satisfaction with surgery, had more 
pain relief, and returned to work faster than patients 
with no CP [12,13]. However, most people believe that 
the role of the CP in the diagnosis of DLBP is limited, 
not only because of its relatively low sensitivity and 
specificity, but also because of a lack of a uniform 
standard of identifying patients with the CP. Fur-
thermore, some patients cannot finish spinal assess-
ments, so the CP has a narrower than desired scope of 
clinical application as a diagnostic indicator.   
BVT, which is the application of blunt electric 
vibrators to the spinous processes of vertebrae, which 
provokes pain originating from the disc, is considered 
by some to be a fast, safe and effective test for DLBP 
[14]. Yrjama and Vanharanta [15] first introduced BVT 
in 1994. In their analysis of 57 patients with chronic 
LBP, they found a high correlation between BVT and 
positive discography, with a sensitivity and specificity 
of 71% and 63%, respectively. These values rose to 
96% and 72% when patients who previously received 
spinal surgery or had a herniated disc were excluded. 
Yrjama and Vanharant then conducted two additional 
experiments using BVT in combination with other 
imaging modalities [16,17]. The combination of BVT 
with ultrasound imaging was 90% sensitive and 75% 
specific for the diagnosis of DLBP. BVT in combina-
tion with MRI was found to be 88% sensitive and 75% 
specific. However, Steven et al. [14] commented that 
the accuracy of the Yrjama study was lacking because 
it included patients with radiculitis and did not show 
that BVT could substitute for discography. Thus, most 
researchers believe that BVT and the CP are of little 
utility and cannot effectively distinguish DLBP from 
other chronic LBP diseases.  
Magnetic resonance imaging (MRI) 
The most commonly used method for diagnos-
ing DLBP is non-invasive MRI technology. An MRI of 
DLBP shows low signal intensity of the disc on T2W, a 
high-intensity zone (HIZ) at the rear of the disc, and 
end plate changes. 
Low signal intensity of the disc on sagittal T2W 
Age-related disc degeneration is associated with 
nucleus dehydration and matrix degradation, causing 
the T2W MRI signal intensity to decrease and result-
ing in a "black disc" (Figure 2). Studies have suggested 
that almost all discs showed reduced signal intensity 
upon sagittal T2W imaging in patients with varying 
degrees of disc degeneration and chronic LBP [18]. 
According to the extent of the reduced signal strength, 
Pfirrmann et al. [19] classified degeneration into five 
grades: I, which represents a normal disc, and II, III, 
IV and V, which respectively represent light to severe 
degeneration. However, many scholars believe that 
the parameter of low-signal intensity does not reflect a 
clear change in disc morphology and is only mini-
mally associated with the amount of pain caused by 
DLBP [20-22]. In addition, in degenerative segments 
of lumbar vertebrae, it is not possible to distinguish 
which disc in the low signal intensity area has actually 
generated pain. In a study of healthy discs, Collins 
[20] found that 17% of discs had low signal intensity 
on T2W imaging. Therefore, low signal intensity of 
the disc has almost 100% sensitivity but a low speci-
ficity for DLBP; therefore, it is not suitable as a diag-
nostic tool. 
 Int. J. Biol. Sci. 2009, 5 
 
http://www.biolsci.org 
650
 
Figure 2. T1 (A)- and T2 (B)-weighted MRI images of the 
spine show intervertebral disc signal intensity variations. 
Arrows point to pathological features (Adopted from Ma-
jumdar [18]). 
High-intensity zone (HIZ) 
In 1992, Aprill and Bogduk [23] first described 
what is now known as the High-intensity zone (HIZ) 
seen on MRI of the lumbar spine. HIZ was a 
‘high-intensity signal’ (bright white) located in the 
posterior annulus fibrosus. It is clearly dissociated 
from the signal of the nucleus pulposus in that it is 
surrounded superiorly, inferiorly, posteriorly and 
anteriorly by the low-intensity (black) signal of the 
annulus fibrosus and is appreciably brighter than the 
signal of the nucleus (Figure 3). A close association 
between HIZ and disc pain was observed in some 
studies. It is suggested that inflammation of the an-
nular fibrosus fissure causes the HIZ to appear, and 
this inflammation also causes irritation of pain fibers. 
The presence of the HIZ has a sensitivity of 82%, a 
specificity of 89%, and a positive predictive value of 
90% for DLBP. Other studies have indicated that the 
presence of the HIZ is a good indicator for DLBP. One 
study [24] found that HIZ had a specificity of 92.5% 
and a positive predictive value (PPV) of 88.9%, but a 
sensitivity of only 26.7% for DLBP. Another study [25] 
showed a sensitivity of 81%, a specificity of 79% and a 
PPV of 87% for HIZ as an indicator of DLBP. Peng et 
al. [26] found that the HIZ had a 100% sensitivity and 
specificity for discs classified as having a grade 3 tear 
according to the Dallas discogram description. How-
ever, some scholars question the utility of the pres-
ence of the HIZ because the mechanism causing it is 
still unproven, and the asymptomatic normal popula-
tion has a high proportion of HIZ on im-
aging as well. Carragee et al. [27,28] found 
the occurrence rate of the HIZ to be 59% in 
patients compared to 25% in asympto-
matic volunteers, and there was no rela-
tionship between the presence of the HIZ 
and chronic LBP. Another study of as-
ymptomatic volunteers found the inci-
dence of the HIZ to be 39% [29]. In a lon-
gitudinal study, Mitraet et al. [30] showed 
no relationship between the presence of 
the HIZ and both the visual analog scale 
(VAS) of DLBP pain intensity and the OQS 
score of disability. This study also deter-
mined that several factors were responsi-
ble for the high positive rate of HIZ pres-
ence on imaging; these factors included a 
small sample, loose exclusion standards, 
and research method bias. Overall, most clinicians 
and academicians consider the presence of the HIZ to 
be an indicator with a high sensitivity and low speci-
ficity. 
 
 
Figure 3. Sagittal T2-weighted magnetic resonance image 
(MRI) shows a high-intensity zone (arrow) within the pos-
terior annulus at L4-L5 (a). Axial T2-weighted MRI shows a 
high-intensity zone (arrow) within the posterior annulus at 
L4-L5 (b). The rectangle indicates the range of disc excision Int. J. Biol. Sci. 2009, 5 
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(PLIF procedure) that is used for histological examination 
(Adopted from Baogan Peng et al. [26]). 
 
Modic changes 
Altered signal strength is often seen in MRIs of 
degenerative spinal disease in the vertebral end plate 
and bone under the cartilage. In 1998, Modic et al. 
[31,32] summarized these changes into groups known 
as Modic Changes (MCs). The MCs classification is 
divided into three groups. Type I, also known as the 
inflammatory phase, is denoted by inflammation of 
fibrous tissue, low signal intensity on T1W and high 
signal intensity on T2W imaging. Type II, known as 
the fat phase, is marked by a large deposition of fat 
cells in the end plate and the area underneath it, as 
well as a high signal intensity on T1W and an 
equivalent or mildly high signal on T2W imaging. 
Type III, also known as the bone sclerosis period be-
cause the bone becomes hardened in the end plate and 
the area underneath it, is also characterized by low 
signal intensity in T1W and T2W imaging (Figure 4). 
Although the etiology has not been fully elucidated, 
MCs remains a useful parameter set for characterizing 
morphological changes to the disc. Studies have 
found that the prevalence of MCs varies from 18 to 
62% in patients with chronic LBP, with different ratios 
relative to asymptomatic patients for each type. Spe-
cifically, MCs types I and II were highly prevalent in 
patients with chronic LBP [34-37] and minimally 
prevalent in asymptomatic volunteer patients [38,39]. 
Albert et al. [34] found a strong correlation between 
MCs and chronic LBP, specifically type I MCs, which 
reflected the pathological results of changes to the end 
plate fissure and the subsequent inflammatory re-
sponse. Kjaer et al. [40,41] reached a similar conclu-
sion in an analysis of 412 40-year old Danish patients. 
Later, Kuisma et al. showed that type I MCs may be 
more related to chronic LBP than types II and III. At 
present, one study has shown a clear relationship 
between clinical symptoms and MCs on MRI [42]. 
Another study [43] using discography as a reference 
standard found that MCs were significantly related to 
pain of varying consistency. Buttermann et al. [44] 
found that the sensitivity of MCs for the diagnosis of 
discogenic pain was relatively high but did not give a 
specific value. In short, studies have found a close 
relationship between MC, the pain of DLBP and posi-
tive results with discography. The MC parameter has 
a high sensitivity but slightly lower specificity as an 
indicator of DLBP.  
 
Figure 4. MC classification (Adopted from Yue-Hui Zhang et al. [33]) Int. J. Biol. Sci. 2009, 5 
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Discography 
Discography, first reported in 1948 by Lindblom 
[45] and Hirsch [46], was initially used to diagnose 
diseases caused by disc damage and was especially 
useful for evaluating painful discs and making the 
choice of which segments to fuse intra-operatively in 
patients with LBP (Figure 5). Positive discography is 
defined as follows: 1) abnormal morphology of the 
examined disc; 2) consistency of pain by provocation; 
3) no pain experienced by provocation of the nearest 
disc; and 4) less than 3 mL of injected contrast agent. 
[48] Because discography can show shape changes 
similar to non-invasive imaging (such as MRI), it can 
be used to locate the disc causing pain and determine 
the nature of the pain through pain provocation, the 
North American Spine Society made discography the 
diagnostic gold standard for DLBP in 1988. Many 
reports verified the clinical value of discography for 
the diagnosis of DLBP. For example, Walsh et al. [49] 
found the false positive rate of discography to be zero, 
with a specificity of 100%. In a study of the relation-
ship between DLBP and the degree of disc degenera-
tion, Peng et al. [26] found a clear relationship be-
tween DLBP and the Dallas discogram description 
grade. Almost all patients with a grade 3 tear accord-
ing to the Dallas discogram description experienced 
pain. The development of new experimental method-
ologies and imaging technologies has included strict 
inclusion and exclusion standards, application of 
blinded studies, speed and pressure control for the 
injection of a contrast agent, a set definition of the 
degree of consistent pain and the evaluation of psy-
chological factors in patients. For example, some re-
cent studies have shown that if the contrast agent is 
injected with an opening pressure ≤ 50 psi and a speed 
of ≤ 0.08 ml/s, the stimulation of pain receptors was 
eliminated, reducing the potential confusion factor 
[28,50-52]. Other studies [51-53] found that the VAS 
score of consistent pain must be ≥ 4, or even ≥ 6, in 
order to reduce false positive results. Studies of the 
impact of psychological factors upon the diagnostic 
strength of discography [54] have increased its reli-
ability and accuracy. Based on discography, some 
scholars have put forward discblock. [55] However, 
the utility of discography has been in dispute since it 
emerged as a diagnostic technique. The biggest flaw 
was that pain provocation is a subjective measure 
dependent on the patient, which despite quantifica-
tion by the VAS, inevitably yields a high rate of false 
positives in patients with a psychological fear of pain 
or hyperesthesia from chronic pain. In a study of pa-
tients who had received surgery of the ilium and had 
no prior history of chronic back pain, Carragee et al. 
[56] found a false-positive rate for pain provocation of 
50% during discography. Block et al. [57] found that 
patients with LBP and mental disorders are likely to 
have a higher false positive rate during discography 
as well. Ohnmeiss et al. [58] performed the Minnesota 
Multiphasic Personality Inventory upon patients who 
showed normal disc morphology on imaging but who 
experienced pain with provocation and found that the 
inventory score of these patients were significantly 
higher than pain free people. Furthermore, due to its 
invasive nature, discography has many complica-
tions, including allergic reaction to contrast agent, 
discitis, epidural abscesses, and acute protrusion of 
the intervertebral disc. Discography might help in 
surgical decision for level localization but is not a gold 
standard for diagnosing DLBP, its many problems 
make it an unsatisfactory technique for DLBP diag-
nosis.  
 
Figure 5. Lateral discograms show a type 2 lobular pattern 
at L2–L3 (arrowhead), a type 5 ruptured pattern at L3–L4 
(white arrow), and a type 4 fissured pattern at L4–L5 (black 
arrow). The patient was painless at L2–L3 and had con-
cordant pain at L3–L4 and L4–L5 during discography. 
(Adopted from Chae-Hun Lim, et al. [47]). 
 
Ultrasound imaging of intervertebral discs 
Compared to photo imaging, ultrasound imag-
ing is more sensitive to changes in the structure of soft 
tissue, and the use of ultrasound imaging can detect 
the specific site of a lesion by noting sites of changed 
density. Ultrasound imaging reveals detailed infor-
mation regarding changes to the structure of the disc, 
especially the location and extent of fissures of the 
annular fibrosus, and, therefore, has a certain value 
for the diagnosis of discogenic LBP. Naish et al. [59] 
studied ultrasound imaging of dog intervertebral Int. J. Biol. Sci. 2009, 5 
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discs in vitro by dividing intact discs into three parts: 
the front annular fibrosus, the nucleus pulposus, and 
the rear annular fibrosus. Each segment was imaged, 
and Cronbach statistics were calculated. This study 
found imaging of each segment to be highly credible, 
with Cronbach values of 0.924, 0.821 and 0.882 for 
each respective segment. Thus, Naish and colleagues 
concluded that ultrasound imaging could measure the 
extent of disc degeneration and pathological position 
of disc diseases. As mentioned previously, Yrjama et 
al. [16] studied the combination of ultrasound imag-
ing and vibration pain provocation compared with 
discography for the diagnosis of internal annular fis-
sures of the lumbar spine, finding a 90% sensitivity 
and 75% specificity for the combination. This study 
concluded that the combination of these two 
non-invasive methods to accurately determine the 
s o u r c e  o f  p a i n  f r o m  a  t o r n  d i s c  c o u l d  b e  a  u s e f u l  
screening tool for the assessment of DLBP. Unfortu-
nately, limited research about the utility of disc ul-
trasound caused many people to not understand its 
true clinical role. It is specifically useful for the detec-
tion of local lesions of the disc in DLBP.   
High-sensitivity C-reactive protein 
High-sensitivity C-reactive protein (hsCRP) is a 
sensitive systemic marker of low-grade inflammatory 
disease. IL-6, an inflammatory mediator, is the major 
up-regulator of hsCRP gene expression and causes 
elevated serum levels of hsCRP. Patients with chronic 
LBP due to structural damage of a disc have higher 
circulating levels of a number of inflammatory factors, 
such as IL-6 and IL-8, as well as elevated levels of 
hsCRP [3]. A correlation exists between the serum 
level of hsCRP and degree of LBP; therefore, hsCRP 
can be used to diagnose DLBP. A recent analysis [60] 
of the relationship between hsCRP and chronic LBP 
divided 36 patients with chronic LBP into three 
groups: MC 0, MC I and MC II, according to the MCs 
on MRI, and analyzed clinical data as well as serum 
hsCRP levels. Francois R, et al. found that serum 
hsCRP levels in the MC I group were significantly 
higher than the other two groups. Furthermore, they 
found that the MC I group experienced pain the most 
in the morning. This study concluded that hsCRP 
could be used to help clinicians diagnose chronic LBP. 
This conclusion was not without controversy, how-
ever. Sturmer et al. [61] found no clear relationship 
between hsCRP level and level of pain. In a prospec-
tive study, Gebhardt et al. [62] found that hsCRP level 
was not correlated with either level of pain or somatic 
function in patients with chronic LBP. Therefore, the 
utility of hsCRP as a marker for DLBP is uncertain, 
but it represents the first attempt at using a serologic 
marker to diagnose this condition. 
 
Table 1: Characteristics of articles reviewed for clinical diagnosis of DLBP 
Study/ 
Year 
Number of patients  Type of study  Diagnostic indices  Sensitivity  Specificity 
Donelson R et al. [7] 
1997 
63 P;  C  CP  64%  70% 
Young S et al. [9] 
2003 
81 P  CP  47%  100% 
Laslett M et al. [10] 
2005 
107 P;  B  CP  40%  97% 
Long A et al. [11] 
1995 
243  P  CP  a higher return-to-work rate, 68%VS52% 
Karas R et al. [12] 
1997 
126  P  CP  a higher return-to-work rate 
Werneke M et al. [13] 
2001 
223  P  CP  a higher return-to-work rate 
Yrjama et al. [15] 
1994 
57 P  BVT  71%  63% 
Yrjama M et al. [17] 
1997 
33 P  BVT&MRI  88%  75% 
Collins C et al. [20] 
2005 
29 P  Dark  disc  100%  0% 
Weishaupt D et al. [21] 
2001 
50 P;  C  Dark  disc  98%  59% 
Weishaupt D et al. [21] 
2001 
50 P;  C  HIZ  27%  85% 
Aprill C et al. [23] 
1992 
500 P  HIZ  82%  89% 
Saifuddin et al. [24] 
1998 
58 P  HIZ  26.7%  92.5% 
Lam KS et al. [25] 
2000 
73 P;  B  HIZ  81%  79% 
Baogan Peng et al. [26] 
2006 
52 P  HIZ  100%  100% Int. J. Biol. Sci. 2009, 5 
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Carragee E et al. [27] 
2000 
54 
(asymptomatic) 
P; C  HIZ  24%  16% 
Mitra D et al. [30] 
2004 
56 R  HIZ  58%  U 
Albert H et al. [34] 
2007 
181 RA;  C  MC  60%  U 
Karchevsky M et al. [35] 
2005 
106 P  MC  58%  U 
Kleinstuck F et al. [36] 
2006 
53 P  MC  62%  U 
Mitra D et al. [37] 
2004 
670  P  MC  strong correlation with symptoms 
Chung C et al. [38] 
2004 
59 
(asymptomatic) 
P MC  25.4%  U 
Weishaupt D et al. [39] 
1998 
60 
(asymptomatic) 
P MC  10%  U 
Kjaer P et al. [41] 
2005 
412 
(asymptomatic) 
P MC  25%  U 
Braithwaite I et al. [43] 
1998 
58 P;  C  MC  23.3%  96.8% 
Weishaupt D et al. [21] 
2001 
50 P;  C  Discography  38%  100% 
Chae-Hun Lim et al. [47] 
2005 
57 P;  C  Discography  57%  97% 
Derby R et al. [51] 
2005 
13 P  Discography  44%  90% 
Derby R et al. [52] 
2005 
86 P  Discography  U  94.6% 
Derby R et al. [53] 
2005 
106 P;  C  Discography  U  70.6% 
Franc O et al. [61] 
2007 
36  P  hsCRP  correlated with MC I signal changes 
Sturmer T et al. [61] 
2005 
72 
 
P 
 
hsCRP 
 
correlated with acute lumbosciatic pain 
Gebhardt K et al. [62] 
2006 
72  P  hsCRP  correlated with acute lumbosciatic pain 
P=prospective; R=retrospective; C=controlled; RA=randomized; B=blinded; U=unknown 
 
Serodiagnosis 
The most important features for a diagnostic test 
are accuracy, safety and repeatability. The accuracy of 
a diagnostic test is reflected by its sensitivity and 
specificity. Incidence of false positives is reflected by a 
lower specificity, and the incidence of false negatives 
is reflected by a lower sensitivity. Unfortunately, all 
currently existing diagnostic methods for DLBP are 
not ideal in that they lack accuracy; therefore, a more 
accurate and reliable method of diagnosis is required.   
 With the completion of the human genome project, 
scientists have realized that proteins are the major 
executor of physiological functions. Research has of-
ten focused on a single protein, but with modern 
technology, analysis of multiple proteins at the same 
time is now possible through proteomics. Proteomics 
is defined as the functional study of a group of pro-
teins to clarify their expression, function and interac-
tions in order to understand their role in organisms 
and cells. In recent years, proteomics research has 
undergone unprecedented development, resulting in 
a large number of available methods to apply to 
clinical research. This development has enabled 
in-depth searches for complex disease biomarkers 
[63,64]. Biomarkers offer superior methods for the 
diagnosis of disease as well as monitoring of therapy. 
Proteomics enables analysis of serum proteins, which 
are an important element of blood that play an im-
portant role in regulating the stability of blood, 
transport of materials, and coordinate the immune 
response. During the pathogenesis, progression and 
treatment of a disease, proteins from damaged cells 
can enter the bloodstream, altering the spectrum of 
proteins in blood. Certain serum proteins can serve as 
diagnostic markers of the disease that caused their 
release from cells [65]. For example, a myocardial in-
farction causes injury or death to myocardial cells, 
which then release creatine kinase into the blood. In-
creased levels of this protein are used to diagnose the 
occurrence of a myocardial infarction. Thus, clinical 
analysis of serum has become incredibly important in 
healthcare. Recognizing the significance of serum 
proteins, the International Human Proteomic Or-
ganization launched the Human Plasma Proteome 
Project (HPPP) in 2002. The scientific objectives of the 
HPPP include a comprehensive analysis of plasma 
proteins to understand ethnic differences in serum 
protein levels, as well as reveal protein level differ-
ences that denote various physiological and patho-Int. J. Biol. Sci. 2009, 5 
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logical conditions [66]. Most serum proteins, includ-
ing disease biomarkers, are often present in small 
amounts that are difficult to detect using proteomic 
analysis of a small number of samples. Understanding 
how to capture low-abundance proteins is critical to 
facilitating the diagnosis of disease. Rapid develop-
ments in experimental biology, including liquid pro-
tein fingerprinting (Figure 6), which combines 
MALDI-TOF-MS with nano-magnetic microspheres, 
have enabled the acquisition of hydrophobic 
low-abundance proteins of low molecular weight. 
This technique will allow discovery of better bio-
markers of disease that will be reliable and accurate.  
At present, there is still no ideal diagnostic 
method for DLBP in clinical practice, prompting 
many academicians and clinicians to search for an 
accurate and reliable method of diagnosis. Based on 
proteomics strategies that are already in use in a 
number of complex diseases, such as cancer, liver 
disease and asthma, we suggest that a serum bio-
marker might exist for the accurate and reliable di-
agnosis of DLBP. Disc degeneration due to biome-
chanical factors generates tears or disruptions in the 
end plate and the outermost third of the annular fi-
brosis, causing irritation of pain fibers by inflamma-
tory mediators. Although blood vessels and nerve 
endings only exist in the end plate and the outermost 
third of the annular fibrosis of the disc, the progres-
sion of disc degeneration causes new blood vessels 
and nerve endings to grow along the fissure and even 
into the internal nucleus pulposus. Eventually, bands 
of inflammatory granulation tissue are formed. Stud-
ies have found that discs that cause pain display 
growth of many micro-vessels and nerve endings, and 
this growth represents a non-physiologic situation 
[67]. As a result of this increased vascularity in the 
pained disc, the biological and chemical changes from 
disc damage are leaked into the circulatory system. 
Furthermore, through intracellular signal transduc-
tion in response to disc stress, a variety of genes are 
expressed, and these proteins can be released into the 
circulation. We believe that serum proteomics can 
detect the release of these released factors from dam-
aged disc cells, reflecting the pathological changes of 
DLBP. Our group plans to conduct a proteomic 
analysis of the serum of patients with DLBP to iden-
tify candidate proteins that may be serum biomarkers 
of the disease. The plan will divide into four groups: 
lumbar disc herniation group, discogenic low back 
pain group, the non-discogenic chronic low back pain 
group, the control group without low back pain. Our 
aim is to prove whether there are differences among 
the four groups serum protein profiling, whether 
there is a common expression between intervertebral 
disc herniation group and discogenic low back pain 
group, so as to clarify the pathogenesis of discogenic 
low back pain and improve the diagnostic level. 
 
Figure 6. CLINPROT: biomarker profiling Int. J. Biol. Sci. 2009, 5 
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DLBP is a multi-factorial and complex disease. 
Identified specific serum markers of DLBP can be 
used as a diagnostic method for the disease. These 
serum markers represent the likely best clinical 
method for diagnosis for multiple reasons. First, har-
vesting serum is a simple, convenient and safe pro-
cedure. Second, serum biomarkers tend to have a high 
sensitivity and specificity. Third, biomarker analysis 
is easy to standardize and reproduce. Serum pro-
teomics research may also contribute to the under-
standing of the pathogenesis of DLBP at the molecular 
level and result in a satisfactory treatment method. 
Diagnosis of a disease is often conducted by 
analysis of symptoms combined with physical ex-
amination, imaging studies and laboratory tests. 
Physical examination detects disease-induced dys-
function, imaging detects foci of tissue damage, and 
laboratory tests are often an indirect reflection of tis-
sue damage. The diagnosis of DLBP remains an in-
tractable problem, despite the gold standard of dis-
cography in current clinical practice. Undoubtedly, 
researchers will continue to pursue diagnostic meth-
ods that are convenient and economically feasible yet 
are highly specific and sensitive. Serum-based diag-
nostic methods may represent the next direction in 
diagnostic method research for DLBP. 
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